Boston Scientific Corp (BSX)vsMedtronic PLC (MDT)
BSX
Boston Scientific Corp
$56.50
+0.62%
HEALTHCARE · Cap: $83.97B
MDT
Medtronic PLC
$80.00
-2.13%
HEALTHCARE · Cap: $103.96B
Smart Verdict
WallStSmart Research — data-driven comparison
Medtronic PLC generates 72% more annual revenue ($35.48B vs $20.61B). BSX leads profitability with a 17.3% profit margin vs 13.0%. BSX appears more attractively valued with a PEG of 0.68. BSX earns a higher WallStSmart Score of 71/100 (B).
BSX
Strong Buy71
out of 100
Grade: B
MDT
Buy58
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-23.3%
Fair Value
$46.11
Current Price
$56.50
$10.39 premium
Margin of Safety
+27.4%
Fair Value
$107.91
Current Price
$80.00
$27.91 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 100.0% YoY
Large-cap with strong market position
Growing faster than its price suggests
Strong operational efficiency at 20.6%
Generating 1.0B in free cash flow
Large-cap with strong market position
Reasonable price relative to book value
Strong operational efficiency at 20.0%
Generating 2.3B in free cash flow
Areas to Watch
No major concerns identified
Earnings declined 11.8%
Comparative Analysis Report
WallStSmart ResearchBull Case : BSX
The strongest argument for BSX centers on EPS Growth, Market Cap, PEG Ratio. Profitability is solid with margins at 17.3% and operating margin at 20.6%. Revenue growth of 11.6% demonstrates continued momentum.
Bull Case : MDT
The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin. PEG of 1.38 suggests the stock is reasonably priced for its growth.
Bear Case : BSX
No major red flags identified for BSX, but monitor valuation.
Bear Case : MDT
The primary concerns for MDT are EPS Growth.
Key Dynamics to Monitor
BSX profiles as a mature stock while MDT is a value play — different risk/reward profiles.
BSX carries more volatility with a beta of 0.78 — expect wider price swings.
BSX is growing revenue faster at 11.6% — sustainability is the question.
MDT generates stronger free cash flow (2.3B), providing more financial flexibility.
Bottom Line
BSX scores higher overall (71/100 vs 58/100), backed by strong 17.3% margins and 11.6% revenue growth. MDT offers better value entry with a 27.4% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Boston Scientific Corp
HEALTHCARE · MEDICAL DEVICES · USA
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Medtronic PLC
HEALTHCARE · MEDICAL DEVICES · USA
Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?